Abbott Unveils High-Tech Manufacturing Facility
Abbott has officially launched its impressive new manufacturing facility dedicated to diabetes care. This state-of-the-art production site is set to become a cornerstone of the company's efforts in advancing healthcare technologies worldwide.
Strategic Investment in Diabetes Manufacturing
The facility is a significant part of Abbott's €440 million investment plan aimed at bolstering its manufacturing capabilities across two sites in Ireland. As part of this development, Abbott will employ more than 800 skilled individuals in Kilkenny, enhancing its position in the diabetes technology sector.
Global Center of Excellence for Diabetes Care
Abbott's new site not only represents a technological marvel but also is expected to achieve the highest production of FreeStyle Libre sensors globally. These sensors are critical for individuals managing diabetes, providing continuous glucose monitoring that is essential for their daily care.
Political Support and Economic Impact
During the opening ceremony, An Taoiseach, Simon Harris, TD, praised Abbott as a pillar of the Irish economy, highlighting the company's long-standing presence in the region since 1946. The new facility signifies a vote of confidence in Ireland's potential as a leader in high-quality manufacturing and healthcare innovation.
Commitment to Sustainability
Abbott’s dedication to sustainable practices is evident in the construction of the Kilkenny facility. Designed with a fully electric framework, it utilizes six air-to-water heat pumps and is equipped with around 600 solar panels. The facility also incorporates a rainwater collection system for operational needs, ensuring a minimal environmental footprint.
Wider Commitment to Diabetes Care
Abbott is not limiting its advancements to Ireland. The company is also investing £85 million to expand its manufacturing capabilities across Europe, including significant upgrades to its facility in Witney, Oxfordshire, UK. Abbott's FreeStyle Libre portfolio has become a global leader in continuous glucose monitoring, currently aiding over 6 million individuals across more than 60 countries.
About Abbott
Abbott is a prominent player in the global healthcare sector, committed to helping individuals lead healthier lives at every stage. Their innovative range of technologies spans diagnostics, medical devices, nutrition, and branded generic medicines, supported by a dedicated workforce of around 114,000 people serving in over 160 nations.
Frequently Asked Questions
What is the purpose of Abbott's new facility?
Abbott's new facility in Kilkenny focuses on manufacturing diabetes technology, particularly FreeStyle Libre sensors, enhancing their global supply.
How many jobs will the new facility create?
The facility in Kilkenny will create over 800 new jobs, supporting local employment and the economy.
What is the size of the Kilkenny manufacturing facility?
The Kilkenny site spans 30,000 square meters and is outfitted with cutting-edge technologies for diabetes care.
What are FreeStyle Libre sensors?
FreeStyle Libre sensors are innovative glucose monitoring devices that provide real-time insights for individuals managing diabetes.
Is Abbott committed to sustainability?
Yes, Abbott emphasizes sustainable practices, utilizing renewable energy sources and water conservation techniques in their new manufacturing facility.
